PHIO icon

Phio Pharmaceuticals

17 hedge funds and large institutions have $758K invested in Phio Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$284K 397,371 +397,371 New
Renaissance Technologies
2
Renaissance Technologies
New York
$164K 229,980 +48,200 +27%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$153K 214,406 +214,406 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$66K 92,755 +4,246 +5%
Goldman Sachs
5
Goldman Sachs
New York
$41K 57,159 +57,159 New
VKH
6
Virtu KCG Holdings
New York
$20K 27,689 +27,689 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$19K 26,638
BIT
8
BlackRock Institutional Trust
California
$8K 10,877
BFA
9
BlackRock Fund Advisors
California
$2K 2,343 +540 +30%
Bank of America
10
Bank of America
North Carolina
$1K 1,096 +412 +60%
BC
11
Broadfin Capital
New York
-316,010 Closed
Citadel Advisors
12
Citadel Advisors
Florida
-12,319 Closed
UBS Group
13
UBS Group
Switzerland
-8,868 Closed
TRCT
14
Tower Research Capital (TRC)
New York
-337 Closed
IA
15
IFP Advisors
Florida
$0 1 -100 -99%
Morgan Stanley
16
Morgan Stanley
New York
$0 98 -40 -29%
NFG
17
Next Financial Group
Texas
-6 Closed
AIM
18
Advantage Investment Management
Iowa
-6 Closed
BC
19
Barnett & Company
Tennessee
$0 29
AG
20
Advisor Group
Arizona
$0 163
LTFS
21
Ladenburg Thalmann Financial Services
Florida
$0 38
FPF
22
FNY Partners Fund
New York
$0 179 +179 New
Deutsche Bank
23
Deutsche Bank
Germany
$0 1,396 +1,394 +69,700%